AI Science Tracker
EN

TeroACT: A terpenoid bioactivity landscape and discovery platform.

Affiliation not stated in the reviewed material · 28 Dec 2025 · multidisciplinary

Discovery

TeroACT: A terpenoid bioactivity landscape and discovery platform.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Original full text describes TeroACT’s learned terpenoid ranking and reports experimental testing of selected candidates in melanoma models. This supports a narrow AI-guided candidate-to-assay result; the source’s broader biological/mechanistic claims should not be treated as established beyond the reported models.

Technology: terpenoid bioactivity data, computational ranking and melanoma-model assays; candidate activity reported in vitro. AI operation assessed from original Methods.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
terpenoid bioactivity data, computational ranking and melanoma-model assays; candidate activity reported in vitro. AI operation assessed from original Methods.
Limitation / still unknown
Selected candidates were tested in melanoma cell and animal models; these preclinical results do not establish human safety, efficacy, or clinical benefit.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/article/MED/41909737

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse multidisciplinary discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.